The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Daily G-CSFs versus pegfilgrastim (PEG) in cancer patients (pts) undergoing chemotherapy (CT): A multivariate analysis from clinical practice.
D. Almenar-Cubells
No relevant relationships to disclose
C. B. ROIG
No relevant relationships to disclose
E. Jimenez
No relevant relationships to disclose
M. Á. Cruz
No relevant relationships to disclose
J. M. Cuervo
No relevant relationships to disclose
N. Diaz
No relevant relationships to disclose
A. B. Sánchez
No relevant relationships to disclose
A. Galan
No relevant relationships to disclose
V. Giner
No relevant relationships to disclose
M. Codes
No relevant relationships to disclose